Sinovac Biotech (SVA) Cash & Equivalents (2009 - 2026)
Sinovac Biotech's Cash & Equivalents came in at $322.26 million for Q2 2026, up 76.5% from $182.63 million a year earlier.
Powered by 
Analysis
Sinovac Biotech (SVA) Cash & Equivalents (2009 - 2026) Analysis & Trends
At the end of FY2025, Sinovac Biotech's Cash & Equivalents was $488.25 million, up 45.6% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of -14.1% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $335.27 million in FY2024 (-70.2%), $1.12 billion in FY2023 (-71.0%), $3.88 billion in FY2022 (-66.6%) and $11.61 billion in FY2021.
- The five-year range for quarterly Cash & Equivalents is $182.63 million (Q2 2025) to $11.61 billion (Q4 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Sinovac Biotech | 464.94 Mn | -24.98 Bn | - | 322.26 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 322.26 Mn |
| Dec 31, 2025 | 488.25 Mn |
| Jun 30, 2025 | 182.63 Mn |
| Dec 31, 2024 | 335.27 Mn |
| Jun 30, 2024 | 1.07 Bn |
| Dec 31, 2023 | 1.12 Bn |
| Jun 30, 2023 | 1.64 Bn |
| Dec 31, 2022 | 3.88 Bn |
| Jun 30, 2022 | 6.86 Bn |
| Dec 31, 2021 | 11.61 Bn |
| Jun 30, 2021 | 6.84 Bn |
| Dec 31, 2020 | 1.04 Bn |
| Sep 30, 2020 | 150.24 Mn |
| Jun 30, 2020 | 141.34 Mn |
| Mar 31, 2020 | 165.34 Mn |
| Dec 31, 2019 | 152.72 Mn |
| Sep 30, 2019 | 156.70 Mn |
| Jun 30, 2019 | 151.69 Mn |
| Mar 31, 2019 | 149.05 Mn |
| Dec 31, 2018 | 158.17 Mn |
API Access
Sinovac Biotech Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "SVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();